W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

News

26 May, 2022

Position of the Transparency Council – PET/MRI – for oncology indications

26 May, 2022

Position of the Transparency Council – PET/MRI – for neurological indications

26 May, 2022

Position of the Transparency Council – PET/MRI – for neurological indications

26 May, 2022

Position of the Transparency Council – PET/MRI – for cardiac indications

24 May, 2022

The Meeting of the Transparency Council No. 21/2022 of 30.05.2022

23 May, 2022

The Meeting of the Tariffs Council No. 11/2022 of 24.05.2022

19 May, 2022

Invitation to participate in public consultations for non governmental organizations representing patients

18 May, 2022

Opinion of the Transparency Council – posaconazolum

18 May, 2022

Opinion of the Transparency Council – lacosamide

20 April, 2022

Free AOTMiT training – dates April/May 2022

30 March, 2022

Tariff Council meeting 6/2022 on 31.03.2022

28 March, 2022

Opinion of the President – “Programme for early detection of hearing and vision impairment among children aged 6 in the Municipality of Świebodzin for 2022-2024”

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑